Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeTax ProvisionsTax RateTax Rate
Others
Ratios

Terns Pharmaceuticals (TERN) Tax Provisions (2020 - 2023)

Terns Pharmaceuticals' Tax Provisions history spans 4 years, with the latest figure at $49000.0 for Q4 2023.

  • For Q4 2023, Tax Provisions fell 84.59% year-over-year to $49000.0; the TTM value through Dec 2023 reached $239000.0, down 33.24%, while the annual FY2025 figure was $231000.0, 11.15% down from the prior year.
  • Tax Provisions reached $49000.0 in Q4 2023 per TERN's latest filing, down from $58000.0 in the prior quarter.
  • In the past five years, Tax Provisions ranged from a high of $711000.0 in Q4 2020 to a low of $6000.0 in Q2 2022.
  • Average Tax Provisions over 4 years is $130642.9, with a median of $53500.0 recorded in 2023.
  • The largest YoY upside for Tax Provisions was 1100.0% in 2023 against a maximum downside of 84.59% in 2023.
  • A 4-year view of Tax Provisions shows it stood at $711000.0 in 2020, then plummeted by 51.34% to $346000.0 in 2021, then dropped by 8.09% to $318000.0 in 2022, then crashed by 84.59% to $49000.0 in 2023.
  • Per Business Quant, the three most recent readings for TERN's Tax Provisions are $49000.0 (Q4 2023), $58000.0 (Q3 2023), and $72000.0 (Q2 2023).